{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:56:11Z","timestamp":1762505771353},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T00:00:00Z","timestamp":1306800000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020532","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T21:23:29Z","timestamp":1306877009000},"page":"e20532","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficient Targeting of Head and Neck Squamous Cell Carcinoma by Systemic Administration of a Dual uPA and MMP-Activated Engineered Anthrax Toxin"],"prefix":"10.1371","volume":"6","author":[{"given":"Jeffrey M.","family":"Schafer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane E.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Morley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo A.","family":"Molinolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Bugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"DM Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008.","volume":"58","author":"A Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","article-title":"Head and neck cancer.","volume":"345","author":"A Forastiere","year":"2001","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1535-6108(04)00090-X","article-title":"Focus on head and neck cancer.","volume":"5","author":"L Mao","year":"2004","journal-title":"Cancer Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.oraloncology.2008.07.011","article-title":"Dysregulated molecular networks in head and neck carcinogenesis.","volume":"45","author":"AA Molinolo","year":"2009","journal-title":"Oral Oncol"},{"key":"ref6","article-title":"The molecular biology of head and neck cancer.","author":"CR Leemans","year":"2010"},{"key":"ref7","first-page":"137","article-title":"Proteolysis in carcinogenesis.","author":"TH Bugge","year":"2003"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1373\/clinchem.2008.105189","article-title":"Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.","volume":"54","author":"N Emami","year":"2008","journal-title":"Clin Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hed.20365","article-title":"Matrix metalloproteases in head and neck cancer.","volume":"28","author":"EL Rosenthal","year":"2006","journal-title":"Head Neck"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20071037","article-title":"Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity.","volume":"407","author":"Z Shi","year":"2007","journal-title":"Biochem J"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2010.586","article-title":"c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.","author":"R Szabo","year":"2011"},{"key":"ref12","first-page":"197","article-title":"Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.","volume":"24","author":"JR Pettus","year":"2009","journal-title":"Histol Histopathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.10916","article-title":"Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.","volume":"95","author":"A Franchi","year":"2002","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1097-0347(200008)22:5<498::AID-HED9>3.0.CO;2-W","article-title":"Urokinase receptor up-regulation in head and neck squamous cell carcinoma.","volume":"22","author":"M Schmidt","year":"2000","journal-title":"Head Neck"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.oraloncology.2004.05.011","article-title":"Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography.","volume":"40","author":"A Curino","year":"2004","journal-title":"Oral Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1747.2001.01241.x","article-title":"Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin.","volume":"116","author":"J Romer","year":"2001","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1073\/pnas.92.7.2730","article-title":"Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.","volume":"92","author":"A Okada","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/000348949510400902","article-title":"Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.","volume":"104","author":"Y Miyajima","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/00016488709128290","article-title":"Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas.","volume":"104","author":"G Bjorlin","year":"1987","journal-title":"Acta Otolaryngol"},{"key":"ref20","first-page":"113","article-title":"Relationship between head and neck squamous cell carcinomas and fibrinolytic factors. Immunohistological study.","volume":"Otolaryngol","author":"T Itaya","year":"1996","journal-title":"Acta"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/(SICI)1097-0347(199710)19:7<611::AID-HED8>3.0.CO;2-A","article-title":"Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck.","volume":"19","author":"T Yasuda","year":"1997","journal-title":"Head Neck"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/00016489950180342","article-title":"Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients.","volume":"119","author":"M Schmidt","year":"1999","journal-title":"Acta Otolaryngol"},{"key":"ref23","first-page":"499","article-title":"Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.","volume":"151","author":"N Johansson","year":"1997","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/bchm3.1996.377.6.385","article-title":"Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.","volume":"377","author":"M Budihna","year":"1996","journal-title":"Biol Chem Hoppe Seyler"},{"key":"ref25","first-page":"165","article-title":"Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.","volume":"53","author":"D Muller","year":"1993","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcp\/99.1.18","article-title":"Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study.","volume":"99","author":"J Kusukawa","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1601-0825.2000.tb00130.x","article-title":"MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.","volume":"6","author":"B Birkedal-Hansen","year":"2000","journal-title":"Oral Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/hupa.2000.9756","article-title":"Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.","volume":"31","author":"Y Imanishi","year":"2000","journal-title":"Hum Pathol"},{"key":"ref29","first-page":"3975","article-title":"Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck.","volume":"20","author":"P Strojan","year":"2000","journal-title":"Anticancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/1097-0215(20010120)95:1<44::AID-IJC1008>3.0.CO;2-M","article-title":"Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma.","volume":"95","author":"T Yoshizaki","year":"2001","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/bchm3.1995.376.7.401","article-title":"Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.","volume":"376","author":"J Kos","year":"1995","journal-title":"Biol Chem Hoppe Seyler"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.1996.d01-1093.x","article-title":"Cathepsin B and D expression in squamous cell carcinoma.","volume":"135","author":"A Kawada","year":"1996","journal-title":"Br J Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14712598.3.5.843","article-title":"Anthrax toxin: structures, functions and tumour targeting.","volume":"3","author":"S Liu","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin.","volume":"414","author":"KA Bradley","year":"2001","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.","volume":"100","author":"HM Scobie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1073\/pnas.0905409106","article-title":"Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.","volume":"106","author":"S Liu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2010.10.004","article-title":"Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.","volume":"8","author":"S Liu","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen.","volume":"267","author":"SS Molloy","year":"1992","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.","volume":"89","author":"KR Klimpel","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/bi015860m","article-title":"Stoichiometry of anthrax toxin complexes.","volume":"41","author":"J Mogridge","year":"2002","journal-title":"Biochemistry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1073\/pnas.052160199","article-title":"The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.","volume":"99","author":"J Mogridge","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.","volume":"280","author":"NS Duesbery","year":"1998","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/bj3520739","article-title":"Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.","volume":"3","author":"G Vitale","year":"2000","journal-title":"Biochem J 352 Pt"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages.","volume":"248","author":"G Vitale","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.","volume":"79","author":"SH Leppla","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations.","volume":"295","author":"LM Coussens","year":"2002","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0955-0674(98)80044-6","article-title":"Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.","volume":"10","author":"M Johnsen","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Cysteine cathepsins: multifunctional enzymes in cancer.","volume":"6","author":"MM Mohamed","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.seminoncol.2005.08.002","article-title":"Toxin conjugate therapy of cancer.","volume":"32","author":"L Wong","year":"2005","journal-title":"Semin Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnci\/djk065","article-title":"A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.","volume":"99","author":"SA Williams","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1039\/b904890a","article-title":"In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.","volume":"1","author":"ES Olson","year":"2009","journal-title":"Integr Biol (Camb)"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nbt1091","article-title":"Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin.","volume":"23","author":"S Liu","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref53","first-page":"6061","article-title":"Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.","volume":"60","author":"S Liu","year":"2000","journal-title":"Cancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1462-5822.2006.00845.x","article-title":"Characterization of the interaction between anthrax toxin and its cellular receptors.","volume":"9","author":"S Liu","year":"2007","journal-title":"Cell Microbiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e3130","DOI":"10.1371\/journal.pone.0003130","article-title":"Role of N-terminal amino acids in the potency of anthrax lethal factor.","volume":"3","author":"PK Gupta","year":"2008","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0277-5379(88)90335-5","article-title":"Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment.","volume":"24","author":"J Gioanni","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.2910610117","article-title":"Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies.","volume":"61","author":"M Cardinali","year":"1995","journal-title":"Int J Cancer"},{"key":"ref58","first-page":"598","article-title":"Culture characteristics of four permanent lines of human cancer cells.","volume":"15","author":"AE Moore","year":"1955","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.97.5.695","article-title":"Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix.","volume":"97","author":"WF Scherer","year":"1953","journal-title":"J Exp Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jnci\/55.3.555","article-title":"Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor.","volume":"55","author":"S von Kleist","year":"1975","journal-title":"J Natl Cancer Inst"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M210321200","article-title":"Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.","volume":"278","author":"S Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1182\/blood.V90.11.4522","article-title":"Growth and dissemination of Lewis lung carcinoma in plasminogen- deficient mice.","volume":"90","author":"TH Bugge","year":"1997","journal-title":"Blood"},{"key":"ref63","first-page":"38","article-title":"Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors.","volume":"15","author":"K Sugiura","year":"1955","journal-title":"Cancer Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1016\/S0021-9258(18)53698-X","article-title":"Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.","volume":"268","author":"N Arora","year":"1993","journal-title":"J Biol Chem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/1535-7163.MCT-09-0694","article-title":"Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.","volume":"9","author":"RW Alfano","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1158\/1541-7786.MCR-08-0451","article-title":"Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis.","volume":"7","author":"RW Alfano","year":"2009","journal-title":"Mol Cancer Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1535-7163.MCT-08-0024","article-title":"Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells.","volume":"7","author":"RW Alfano","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4161\/cc.7.6.5627","article-title":"Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacy.","volume":"7","author":"RW Alfano","year":"2008","journal-title":"Cell Cycle"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M707419200","article-title":"Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.","volume":"283","author":"S Liu","year":"2008","journal-title":"J Biol Chem"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1158\/0008-5472.CAN-06-4642","article-title":"Systematic urokinase-activated anthrax toxin therapy produces regressions of subcutaneous human non-small cell lung tumor in athymic nude mice.","volume":"67","author":"Y Su","year":"2007","journal-title":"Cancer Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1158\/1078-0432.CCR-06-2019","article-title":"Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.","volume":"12","author":"RJ Abi-Habib","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-06-0315","article-title":"A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types.","volume":"5","author":"RJ Abi-Habib","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.0236849100","article-title":"Potent antitumor activity of a urokinase-activated engineered anthrax toxin.","volume":"100","author":"S Liu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1074\/jbc.M011085200","article-title":"Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin.","volume":"276","author":"S Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","article-title":"The microenvironment of the tumour-host interface.","volume":"411","author":"LA Liotta","year":"2001","journal-title":"Nature"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2010-03-276642","article-title":"Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.","volume":"116","author":"BM Connolly","year":"2010","journal-title":"Blood"},{"key":"ref77","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-05971-5_19","article-title":"Anthrax toxin.","author":"SH Leppla","year":"2000"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/prep.2000.1208","article-title":"Optimized production and purification of Bacillus anthracis lethal factor.","volume":"18","author":"S Park","year":"2000","journal-title":"Protein Expr Purif"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929866023409048","article-title":"Peptide toxins directed at the matrix dissolution systems of cancer cells.","volume":"9","author":"AE Frankel","year":"2002","journal-title":"Protein Pept Lett"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T11:42:50Z","timestamp":1637754170000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020532"}},"subtitle":[],"editor":[{"given":"Olivier","family":"Gires","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":79,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020532","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}